It is with an immense pleasure and a great honor, we would like to welcome you all to the Hybrid (Onsite and Online) Conference on  3rd Edition of Global Pharma Meet & Expo to be held during April 27-29th, 2023. Amsterdam,Netherlands.

The conference is hosted by Linkin Science. These conferences are well crafted and designed by a team of skilled experts. Our conferences are vast expanded into Medical, life sciences, health care, Engineering and other social sciences. Each conference, summit or executive briefing is tailored to the sector, topic and audience need. Our event structure varies depending on issue and market requirements featuring Keynote presentations, Oral talks, Poster presentations, Young research forum, Exhibitions, roundtables and variable formats. Our mission is to bring the researchers on a common platform and provide opportunity for them to interact. This scientific networking helps for the betterment of science by exchanging the ideas in a broader way. Magnifying Scientific Knowledge by Sharing the research and ideas. We believe in accelerating the possibilities of novel discoveries and enhancement in scientific research, by connecting scientific community for knowledge sharing. Join us to redefine and explore new research, to provide a credible source to barter ideas for scientific studies besides transforming the true outcomes of a distinct scientific discovery and grab the attention for rare emerging technologies.

Benefits:

Join your peers around the world focused on learning about Pharmaceutics, Pharmacology and Drug Delivery Systems, which is your best opportunity to reach the largest gathering of participants from the Pharmaceutics community, conduct demonstrations, distribute research information, meet with current and potential professionals who make a splash with new research works, and receive recognition at this 3-day event. World-renowned speakers who include CEO’S and Company Directors, Professors, Researchers, Pharmacologists, Clinical Pharmacists, Pharmacy Associates and Society Members will be taking part at this reputed conference.

Target Audience:

Pharmacology:

Pharmacology is a part of Biology which is concerned with the Drug action studies. Pharmacology is classified into different types. Clinical pharmacology is a branch of Pharmacology related to drugs and their clinical use. Clinical Pharmacology is the most complete, easiest-to-use and most dependable drug information solution available today. Neuropharmacology is the study of how drugs affect the function of Nervous system. Psychopharmacology is the study of the use of medications in treating mental disorders. Cardiovascular pharmacology is the science which evaluates the drugs used in the treatment of Cardiovascular Disorders. Systems pharmacology is an application of system biology principles to the field of Pharmacology. Toxicology is a branch related to Biology, Medicine and Chemistry concerned with the adverse effects of Chemicals on Living organisms. Theoretical pharmacology uses techniques of computational quantum chemistry and the method of Molecular Mechanics. Environmental pharmacology is a branch of pharmacology that deals entry of chemicals or drugs into the environment after elimination from humans and animals as post-therapy. Dental pharmacology is the study of drugs of the oral cavity. 

Targeted Drug Delivery:

Targeted Drug Delivery is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs and tissues or cells. Active targeting involves attaching to the drug delivery system something like an antibody, or carrier protein or a ligand which will allow it to go and meet and complex with the cell having the receptor for the attachment. Passive targeting or physical targeting involves the preparation of a drug carrier complex that can avoid the elimination due to body defense mechanisms like metabolism, excretion and opsonisation followed by phagocytosis. There are different types of drug delivery vehicles, such as polymeric micelles, liposomes, lipoprotein-based drug carriers, nano-particle drug carriers, dendrimers, etc. An ideal drug delivery vehicle must be non-toxic, biocompatible, non-immunogenic, biodegradable and must avoid recognition by the host's defense mechanisms.

Receptors, Drug action and Mechanism:

A receptor is a protein molecule that receives chemical signals from outside a cell. The structures of receptors are very diverse and can broadly be classified into L (Ionic receptors), G protein couple receptors (metabotropic), Kinase-linked and related receptors, Nuclear receptors. Drugs interact with receptors by bonding at specific binding sites. Most receptors are made up of proteins, and the drugs can therefore interact with the amino acids to change the conformation of the receptor proteins. Drugs interact with receptors by bonding at specific binding sites. Most receptors are made up of proteins, and the drugs can therefore interact with the amino acids to change the conformation of the receptor proteins. Drug mechanism of action is determined by Microscopy-based methods, direct biochemical method, Computation inference methods. When talking about the shape of molecules, biochemists are mainly concerned with the three-dimensional conformation of drug molecules. There are many isomers of a particular drug, and each one will have its own effects. Differences in isomer affect not only what the drug activates, but also changes the potency of each drug.

Drug metabolism and excretion:

The metabolism of drugs and other xenobiotics into more hydrophilic metabolites is essential for the elimination of these compounds from the body and termination of their biological activity. The liver is the principal site of drug metabolism. Although metabolism typically inactivates drugs, some drug metabolites are pharmacologically active—sometimes even more so than the parent compound. Drug Metabolism is concerned with Permeability barriers and detoxification, Phases of detoxification, Endogenous toxins and the factors that affect drug metabolism. Excretion is a process whereby drugs are transferred from the internal to the external environment. Despite the reduction in activity that occurs as a drug leaves its site of action, it may remain in the body for a considerable period, especially if it is strongly bound to tissue components. Excretion, along with metabolism and tissue redistribution, is important in determining both the duration of drug action and the rate of drug elimination. Principal organs involved Kidneys, Lungs, Biliary system, Intestines, Saliva, and Milk.

Drug discovery and development:

The idea that the effect of a drug in the human body is mediated by specific interactions of the drug molecule with biological macromolecules, (proteins or nucleic acids in most cases) led scientists to the conclusion that individual chemicals are required for the biological activity of the drug. The first step in the drug discovery process is to identify a suitable target. This is a molecule or a protein receptor that is specifically associated with a disease condition or pathology. For this purpose, it is important to understand how the disease occurs at the molecular, cellular, and genetic levels. The drug development phase involves rigorous testing and optimization of the selected compounds to identify the lead structure or candidate drug’ which might be the most effective. Testing required by the health authorities is done in cells (in vitro) and in animals (in vivo) to study metabolism safety, toxicity, dosage, and efficacy.

Pharmacokinetics and Pharmacodynamics:

Pharmacokinetics is the quantitative study of drug movement in, through and out of the body. Intensity of effect is related to concentration of the drug at the site of action, which depends on its pharmacokinetic properties and these properties of particular drug is important to determine the route of administration, dose, onset of action, peak action time, duration of action and frequency of dosing. Pharmacodynamics is the branch of pharmacology concerned with the action of drugs on the body or on microorganisms within or on the body.

Pharmacoepidemiology and Pharmacovigilance:

Pharmacoepidemiology is the study of drug efficacy, toxicity and patterns of use in large populations. Thus, pharmacoepidemiology can be called a bridge science spanning both pharmacology and epidemiology. Pharmacoepidemiology sometimes also involves the conduct and evaluation of programmatic efforts to improve medication use on a population basis.  Pharmacovigilance is a type of continual monitoring for unwanted effects and other safety-related aspects of drugs that are already on the market. Pharmacovigilance has been defined by the World Health Organisation as “The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problem”

Pharmacogenetics and Genomics:

Pharmacogenetics is the study of how the actions of and reactions to drugs vary with the patient's genes. Pharmacogenetics studies the genetic variation between people underlying differential response to drugs. Genes determine the make-up of all the body's proteins, and as medicines travel through the body they interact with many of these proteins. This relatively new field allows us to combine pharmacology and genomics to develop effective and safe medication dosages which are specific to an individual’s DNA makeup. 

Pharmaceutical engineering:

Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry. A pharmaceutical engineer is a specialized chemical engineer who focuses on creating new pharmaceutical drugs and improving upon existing products and manufacturing processes. Pharmaceutical engineering is subject to various regulations in different countries, and pharmaceutical engineers must ensure they maintain personal and environmental safety at all times.

Pharmaceutical formulation:

Pharmaceutical formulation is a process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. The pharmaceutical formulations process involves the entire process of a how a drug is developed and how it is finally accepted by the patient. The drug form varies by the route of administration. Like capsules , tablets and pills etc. Parenteral formulations also called injectable formulations and are used with intravenous, subcutaneous, intramuscular, and intra-articular administration. In the pharmaceutical drug formulations, the different physical, chemical, and mechanical properties of a drug are considered so as to know what other ingredients should be used in the preparation.

Pharmaceutical microbiology:

Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals like minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial by-products like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile. The most important contribution of microbiology to the pharmaceutical industry is the development of antibiotics. Apart from drugs and bio products development, microbiology contributes towards quality control of a pharmaceutical laboratory. Prevention of microbial contamination of drugs, injectables, eye drops, nasal solutions and inhalation products is undertaken following pharmacopeial guidelines.

Pharmacognosy:

Pharmacognosy is the study of medicines or crude drugs produced from natural sources such as plants, microbes, and animals. It includes analysis of their biological, chemical, biochemical, and physical properties. It includes the study of various disciples such as ethnobotony, ethnopharmacology, Phytotherapy, Phytochemistry, Zoopharmacognosy, Marine pharmacognosy etc. The part of pharmacognosy focusing on the use of crude extracts or semi-pure mixtures originating from nature, namely phytotherapy, is probably the best known and also the most debated area in pharmacognosy. 

Medicinal Chemistry:

Medicinal chemistry is the chemistry discipline concerned with the design, development and synthesis of pharmaceutical drugs. The discipline combines expertise from chemistry and pharmacology to identify, develop and synthesize chemical agents that have a therapeutic use and to evaluate the properties of existing drugs.

Biopharmaceutics:

Biopharmaceutics is the study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action, including coconstituents and mode of manufacture. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biopharmaceuticals are majorly extracted from living systems (Whole blood and other blood components, Organs and tissue transplants, Stem cell therapy, Antibodies for passive immunization, Human breast milk, Fecal microbiota, Human reproductive cells) produced by recombinant DNA (Body’s own signelling proteins like Erythropoetin, Human insulin etc and other Monoclonal antibodies and fusion proteins) Major kinds of biopharmaceuticals include Blood factors, Thrombolytic agents, Hormones, Haematopoietic growth factors, Interferons, Interleukin-based products, Vaccines, Monoclonal antibodies etc.

Pharmacotherapy:

Pharmacotherapy is the Study of the use and effects produced by drugs on patients as well as the treatment of illnesses by administering drugs. Pharmacists are experts in pharmacotherapy and are responsible for ensuring the safe, appropriate, and economical use of pharmaceutical drugs. The skills required to function as a pharmacist require knowledge, training and experience in biomedical, pharmaceutical and clinical sciences.

Process Validation, Qualification and Good Manufacturing Practices:

Validation is establishing documented evidence which provides a high degree of assurance that a specific process or equipment will consistently produce a product or result meeting its pre-determined specification and quality attributes. Validation is a key process for effective Quality Assurance. A GMP is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production from the starting materials, premises and equipment to the training and personal hygiene of staff. 

Hospital pharmacy:

Hospital Pharmacy is a department or service in a hospital, responsible for the supply of medications to hospital wards as well as ambulatory patients, The department is headed by professionally competent, legally qualified pharmacist who directly supervises and ensures the correct dispensing, compounding, and distribution of medication to in and out-patients. The major goals include providing the benefits of a qualified hospital pharmacist to patients and health care institutions, to the allied health professions, and to the profession of pharmacy, To assist in providing an adequate supply of such qualified hospital pharmacists, To assure a high quality of professional practice through the establishment and maintenance of standards of professional ethics, education, and attainments and through the promotion of economic welfare, To promote research in hospital pharmacy practices and in the pharmaceutical sciences in general, To disseminate pharmaceutical knowledge by providing for interchange of information among hospital pharmacists and with members of allied specialties and professions.

BioInformatics:
Bioinformatics includes biological studies that use computer programming as part of their methodology, as well as specific analysis "pipelines" that are repeatedly used, particularly in the field of genomics. Common uses of bioinformatics include the identification of candidates genes and single nucleotide polymorphisms (SNPs). Often, such identification is made with the aim to better understand the genetic basis of disease, unique adaptations, desirable properties (esp. in agricultural species), or differences between populations. In a less formal way, bioinformatics also tries to understand the organizational principles within nucleic acid and protein sequences, called proteomics.

Pharmaceutical Management:

Pharmaceutical Management is a division of management that deals with chemical and health sciences and ensures the effective and safe use of pharmaceutical drugs.  Pharmaceutical Management integrates business strategy with science and technology and the unique perspective of the industry.

Market Analysis:

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

Europe is one such region which encompasses the major share of the Pharmacology and Toxicology research. Spain being one of the most advanced European economies is bound to hold the chief share in Europe’s Pharmacology market. Further as EU expands the research, export and trading relations are bound to enhance.

Market Analysis of Global Pharmaceutical Industries

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

According to the QuintilesIMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Major Pharmacology Associations around the Globe

• American Academy of Veterinary Pharmacology and Therapeutics
• American Board of Clinical Pharmacology
• Argentine Society for Experimental Pharmacology
• Association of Pharmacologists of Ukraine
• Australian Physiological and Pharmacological Society
• British Association for Psychopharmacology
• Colombian Association of Pharmacology

Exhibitors who would like to participate in Virtual mode, we provide a custom designed virtual trade booths. Companies who would like to participate onsite can send an email to pharmameet@linkinscience.com or download the exhibitor brochure for detailed information.

Customizable Virtual Booths with the ability to upload logos, company offerings, social media presence, UNLIMITED files and videos for attendees to view. Immediate leads for any attendee that visits your booth or sets up a one-on-one virtual appointments. Opportunity to chat and communicate with attendees during LIVE virtual exhibit hours. With interactive features, that allow for video chats, pre-set appointments, and industry tours - the possibilities are endless!

REACH A LARGER AUDIENCE 
Attendees can access the Virtual Event from ANYWHERE - Bringing you relevant, diverse interactions with attendees from different market segments around the world. Meaning MORE attendees will get to see your company profile, products and services more efficiently.

GLOBAL PARTICIPATION – Attendees are not limited by their geographic locations – ALL parts of the world can attend!

COST-EFFECTIVE – Virtual Events provide the opportunity for additional staff participation and the opportunity to showcase additional products, services, and equipment.

CONVENIENT INTERACTIONS - Attendees will have the option to chat and communicate with a virtual expo representative during LIVE virtual exhibit hours. With interactive features, that allow for video chats, pre-set appointments, and industry tours.

Attendees will have dedicated time to visit exhibitors to learn about the latest products, services and solutions through literature, videos, social media, and meeting with representatives.

Corporate Exhibit Virtual Branding Package $1000

• Post-Show Attendee List (emails  included)
• Leads from attendees that set appointments and/or visit your booth (emails included)
• Customizable Virtual Booth with ability to upload logos, company offerings, and social media presence
• Company Logos with URL on Virtual Edition Website
• The Attendee “Virtual Booth Crawl” – Attendees come to YOU!
• Industry Tour - Company supplied 1-minute video posted on the event LOP website
• Access to Virtual Leads & Sponsor Messaging: View list of attendees and send private messages to arrange appointments and virtually meet attendees via chat or on video
• Enhanced Search Options for Attendees making it easy for them to search for your company name directly or by product categories

Why You Should Exhibit or Advertise at the

Pharma 2023 – The Hybrid Edition Event:

MAXIMUM exposure to thousands of leads

Opportunity to acquire NEW customers that cannot attend events

Interact with attendees & capture VERIFIED LEADS with full contact information

Raise brand awareness with continuous promotion – even AFTER the show ends

Efficient spend on virtual event and marketing budget with limited staff time needed

Hybrid Conference: This kind of event allows participants to join as per their convenience and choice of participation. It can be either onsite or Virtual; we ensure you have a wonderful learning experience at our events.

In-Person Attendance

Participants will be able to follow the physical sessions at the meeting halls. All the necessary precautions are taken at the event venue along with social distancing, sanitisation and wearing a mask is mandatory.

Virtual Attendance

Participants will be able to access the virtual content with the login information that will be sent to the e-mail address they have registered. We will project the virtual participant presentation on the screen and the talk will be delivered.

Participants can watch the presentation and send questions to the speaker or engage other delegates.

All conference presentations are broadcasted via webcast so you can watch from the comfort of your own office or home. All the features of an in-person event will still be available (Keynote sessions, Oral Presentations, Poster presentations, exhibit halls, networking, questions with presenters, downloadable collateral, etc.).

Exhibition

Virtual participants will be able to enter the virtual exhibition area and contact exhibiting companies by clicking on the name / logo of them. There will also be a physical exhibition area for the in-person participants.

Oral Presentation Sessions

During oral presentation sessions, speakers will present their works live within the specified time. The authors will also be able to make a virtual presentation if they cannot attend in-person.

Poster Presentation Sessions

Poster Presentations will be made in a PDF format accompanied by a video of a maximum of 10 minutes of the poster presenter. Attendees will have the opportunity to ask questions to the authors directly. The authors will also be able to make a virtual presentation if they cannot attend in-person.

How will virtual participants access the Hybrid conference?

• Virtual attendees will receive an email with login instructions 3-5 days before the event. We encourage all attendees to log into the platform before the conference starts to make sure you can login. If you have trouble logging in, please email pharmameet@linkinscience.com

• The conference will start at 9.30 am during the conference dates, so attendees should be logged into the virtual platform by 9:00 am.

What are the technical requirements for virtual participation?

• Laptop or personal computer

• Strong, reliable wifi connection

• Google Chrome is recommended to run the Virtual Conference platform.

Can I watch the live stream sessions on my phone or tablet or computer?

Yes, the Virtual Conference is accessible via a smart phone or tablet or computer/laptop.

Which sessions are going to be recorded?

All sessions will be recorded during the event and will be made available to attendees approximately 1-2 days after the event and be available for 12 months after release. Recordings will also include the session slides. If your registration includes access to the recordings, you will receive instructions for accessing them via email following the conference. Please refrain from personal recording as speakers may want to edit the recording before release.

Can I get a certificate of completion after attending virtual conference?

Yes, we will email soft copy of your certificate 2 days after the conference.

Where can I review the Program schedule of the online conference?

You can explore the speakers, topics, and schedule before the conference through agenda present in the website. This final agenda will be made available 5 days prior to the conference.

Can I ask the speaker a question or make a comment during a live session?

Questionnaire will there at end of each talk/presentation. Listeners can question and clarify their doubts. There will also be a chat box in which you can send messages for speakers to see.